x

Posted 14 October, 2021

LEGACY VENTURES INTERNATIONAL INC. appointed Mr. Ying Feng LAI as new CEO

OTC:LGYV appointed new Chief Executive Officer Mr. Ying Feng LAI in a 8-K filed on 14 October, 2021.


  Mr. Ying Feng LAI has been appointed as a Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and Directors of the Company since October 14, 2021.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of LEGACY VENTURES INTERNATIONAL INC.
Real Estate/Construction • Real Estate Developers
Legacy Ventures International, Inc. engages in incurring general and administrative expenditures. The company was founded by Rehan Saeed and Zeeshan Saeed on March 4, 2014 and is headquartered in Hong Kong.
Market Cap
$126M
View Company Details
LEGACY VENTURES INTERNATIONAL INC. by TradingView
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 


On October 14, 2021, the existing officer resigned immediately, and also will be resigning as a director on the day which is 10 days from the date of mailing of the Company's filing of an Information Statement Pursuant to Section 14(f) of the Securities Exchange Act of 1934 and Rule 14f-1 thereunder. Accordingly, Peter Sohn, serving as a director and an officer, ceased to be the Company's Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary, and will cease to be a Director on or about October 25, 2021. At the effective date of the transfer, Ying Feng LAI consented to act as the new Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and a Director of the Company.


Mr. Ying Feng LAI ("Mr. LAI"), age 30, obtained his Diploma of Business Administration in the Columbia College in Canada in 2012.


From January 2012 to March 2016, Mr. LAI was an assistant operation commissioner of Aquaporin Industries Limited, a water tech company delivering innovative technology built on nature's own water filtration. ("Aquaporin") Aquaporin had three target markets, namely industrial water, drinking water and hemodialysis. Mr. LAI was responsible for resources planning and management including hiring and interviewing, training, coaching, developing, objective setting and performance management.


Since April 2016, Mr. LAI has been a Vice President of Operation of Zeus Medicine Pharmaceutical Group Limited, a manufacturing company on branded and generic medicines and medical supplies. ("Zeus") Mr. LAI is responsible for the leading, developing and mentoring manufacturing operation.


Mr. Ying Feng LAI has been appointed as a Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and Directors of the Company since October 14, 2021.